Prestalia (perindopril arginine) is a small molecule pharmaceutical. Perindopril arginine was first approved as Prestalia on 2015-01-21. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. Prestalia's patent is valid until 2029-10-05 (FDA).
|Common Name||Perindopril arginine|
|Indication||diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction|
|Drug Class||Antihypertensives (ACE inhibitors)|